Research Article
Volume 10 Issue 7 - 2022
Pharmacological Evaluation of the Antidiabetic Effect of the Leaf Crude Extract of Hagenia abyssinica on Normoglycemic, Oral Glucose Loaded, and Streptozotocin-Induced Diabetic Mice; A Single Dose Study

Zemene Demelash Kifle1*, Yaschilal Muche Belayneh2, Alem Endeshaw Woldeyohanin3, Habtamu Assefa4, Tesfaye Yimer5 and Dawit Kumilachew Yimenu3

1Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

2Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia

3Department of Social Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

4University of Gondar Comprehensive and Specialized Hospital

5Department of Pharmacy, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia

*Corresponding Author: Zemene Demelash Kifle, Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Received: May 02, 2022; Published: June 29, 2022


Background: In Ethiopian traditional medicine, the leaves of H. abyssinica (Rosaceae) have been used to treat diabetes mellitus. However, the anti-diabetic efficacy of H. abyssinica leaves crude extract has not been properly examined. The goal of this study was to see if the crude extract of H. abyssinica on might prevent diabetes in normoglycemic, oral glucose-loaded, and STZ-induced diabetic mice.

Methods: Successive maceration was used as a method of extraction using solvents of increasing polarity: methanol and water. After extraction of the leaves with 80% hydro methanol, the crude extract was evaluated for its anti diabetic activities using oral glucose loaded, normoglycemic, and single dose-treated diabetic mice model. The extract was evaluated at 100, 200 and 400 mg/kg doses. One-way ANOVA followed by Tukey’s post hoc test was used for data analysis, and p < 0.05 was considered as statistically significant.

Results: The acute toxicity study of H. abyssinica leaf extract did not show mortality in the animals at the limit dose of 2000 mg/kg during the observation period. In normoglycemic model, the percentage reduction of baseline blood glucose level (BGL) was 26.08%, 32.90%, 35.24%, and 53.61% for Hagenia abyssinica crude extract (HAC) 100 mg/kg, HAC 200 mg/kg, 400 mg/kg, and glibenclamide (GLC) 5 mg/kg, respectively when compared to the negative control. The extract at the dose of 200 mg/kg, 400 mg/kg, and GLC treated groups demonstrated significant BGL reduction from peak levels in the OGTT model. In STZ-induced diabetic mice, all doses of the crude extract showed a significant reduction in the fasting BGL. At the 8th hour, the highest percent reductions in blood glucose level (BGL) were recorded in HAC100, HAC200, HAC400 and GL5 with 26.78%, 31.27%, 43.53% and 51.72% reduction respectively compared to their respective baseline fasting BGL levels.

Conclusion: H. abyssinica leaf extract displays antidiabetic activity in normal and STZ-induced diabetic mice, which justifies the claimed traditional use of H. abyssinica in managing DM in Ethiopian folk medicine.


Keywords: Antidiabetic; Diabetes Mellitus; Hagenia abyssinica; Hypoglycemia and Streptozotocin



  1. Lubberding AF., et al. “Age-dependent transition from islet insulin hypersecretion to hyposecretion in mice with the long QT-syndrome loss-of-function mutation Kcnq1-A340V”. Scientific Reports1 (2021): 1-14.
  2. Oyedemi S., et al. “Antidiabetic activities of aqueous leaves extract of Leonotis leonurus in streptozotocin induced diabetic rats”. Journal of Medicinal Plants Research1 (2011): 119-125.
  3. Cho N., et al. “IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045”. Diabetes Research and Clinical Practice 138 (2018): 271-281.
  4. Chávez-Silva F., et al. “Antidiabetic effect of Achillea millefollium through multitarget interactions: α-glucosidases inhibition, insulin sensitization and insulin secretagogue activities”. Journal of Ethnopharmacology 212 (2018): 1-7.
  5. Association AD. “Diagnosis and Classification of Diabetes Mellitus”. Diabetic Care2 (2014).
  6. Nivedita Tiwari AKT., et al. “Therapeutic targetes of diabetes mellitus: An update”. Research Gate1 (2014): 1-11.
  7. Thulé PM and G Umpierrez. “Sulfonylureas: a new look at old therapy”. Current Diabetes Reports4 (2014): 473.
  8. Hundal RS., et al. “Mechanism by which metformin reduces glucose production in type 2 diabetes”. Diabetes12 (2000): 2063-2069.
  9. Ahmadian M., et al. “PPARγ signaling and metabolism: the good, the bad and the future”. Nature Medicine5 (2013): 557-566.
  10. Bischoff H. “The mechanism of alpha-glucosidase inhibition in the management of diabetes. Clinical and investigative medicine”. Medecine Clinique et Experimentale4 (1995): 303-311.
  11. Mohamed Eddouks., et al. “Animal Models as Tools to Investigate Antidiabetic and Anti-Inflammatory Plants”. Evidence-Based Complementary and Alternative Medicine (2012): 14.
  12. Organization WH. “Global report on diabetes”.: World Health Organization (2016).
  13. Feyissa T. “Micropropagation, transformation and genetic diversity of Hagenia abyssinica (Bruce)”. JF Gmel (2006).
  14. Beentje H., et al. “Kenya trees, shrubs, and lianas”.: National Museums of Kenya (1994).
  15. Assefa B., et al. “Ethnomedicinal uses of Hagenia abyssinica (Bruce) JF Gmel. among rural communities of Ethiopia”. Journal of Ethnobiology and Ethnomedicine1 (2010): 20.
  16. Enyew A., et al. “Ethnobotanical study of traditional medicinal plants in and around Fiche District, Central Ethiopia”. Current Research Journal of Biological Sciences4 (2014): 154-167.
  17. Lunyera J., et al. “Traditional medicine practices among community members with diabetes mellitus in Northern Tanzania: an ethnomedical survey”. BMC Complementary and Alternative Medicine1 (2016): 282.
  18. Mekuria AB., et al. “Prevalence and correlates of herbal medicine use among type 2 diabetic patients in Teaching Hospital in Ethiopia: a cross-sectional study”. BMC Complementary and Alternative Medicine1 (2018): 85.
  19. Habte BM., et al. “Explanatory models of adult patients with type 2 diabetes mellitus from urban centers of central Ethiopia”. BMC Research Notes1 (2016): 441.
  20. Bnouham M., et al. “Medicinal plants with potential antidiabetic activity-A review of ten years of herbal medicine research (1990-2000)”. International Journal of Diabetes and Metabolism1 (2006): 1.
  21. Patel D., et al. “An overview on antidiabetic medicinal plants having insulin mimetic property”. Asian Pacific Journal of Tropical Biomedicine4 (2012): 320.
  22. Kifle ZD., et al. “In Vitro α-Amylase and α-Glucosidase Inhibitory and Antioxidant Activities of the Crude Extract and Solvent Fractions of Hagenia abyssinica Leaves”. BioMed Research International (2021).
  23. Kifle ZD and YM Belayneh. “Antidiabetic and Anti-hyperlipidemic Effects of the Crude Hydromethanol Extract of Hagenia abyssinica (Rosaceae) Leaves in Streptozotocin-Induced Diabetic Mice”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 13 (2020): 4085.
  24. Demissew S., et al. “Four new species of Aloe (Aloaceae) from Ethiopia, with notes on the ethics of describing new taxa from foreign countries”. Kew Bulletin1 (2011): 111-121.
  25. Grover J., et al. “Medicinal plants of India with anti-diabetic potential”. Journal of Ethnopharmacology1 (2002): 81-100.
  26. Vuksan V and JL Sievenpiper. “Herbal remedies in the management of diabetes: lessons learned from the study of ginseng”. Nutrition, Metabolism and Cardiovascular Diseases3 (2005): 149-160.
  27. Wolde T., et al. “Phytochemical analysis and Antimicrobial activity of HAGENIA ABYSSINICA”. Indian Journal of Pharmacy and Pharmacology3 (2016): 127-134.
  28. OCDE O. “Acute oral Toxicity: Up and Down Procedure”. OECD. Guideline for the Testing of Chemicals 425 (2008): 1-2.
  29. Deeds M., et al. “Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models”. Laboratory Animals3 (2011): 131-140.
  30. Furman BL. “Streptozotocin‐induced diabetic models in mice and rats”. Current Protocols in Pharmacology (2015): 5-47.
  31. Vital PLE and Hiriart M. “Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats”. Journal of Endocrinology2 (2006): 425-432.
  32. Tamiru W., et al. “Evaluation of the effects of 80% methanolic leaf extract of Caylusea abyssinica (fresen.) fisch. and Mey. on glucose handling in normal, glucose loaded and diabetic rodents”. BMC Complementary and Alternative Medicine1 (2012): 151.
  33. Birru EM., et al. “Effect of hydroalcoholic leaves extract of Indigofera spicata Forssk. on blood glucose level of normal, glucose loaded and diabetic rodents”. BMC Complementary and Alternative Medicine1 (2015): 321.
  34. Tesfaye A., et al. “Hypoglycemic and antihyperglycemic activity of aqueous extract of Justicia Schimperiana leaves in normal and streptozotocin-induced diabetic mice”. International Journal of Pharma Sciences and Research2 (2016): 110-113.
  35. Baquer NZ., et al. “Metabolic and molecular action of Trigonella foenum-graecum (fenugreek) and trace metals in experimental diabetic tissues”. Journal of Biosciences2 (2011): 383-396.
  36. Belayneh YM., et al. “Evaluation of hypoglycemic, antihyperglycemic and antihyperlipidemic activities of 80% methanolic seed extract of Calpurnia aurea (Ait.) Benth.(Fabaceae) in mice”. Journal of Experimental Pharmacology 11 (2019): 73.
  37. Belayneh YM and EM Birru. “Antidiabetic Activities of Hydromethanolic Leaf Extract of Calpurnia aurea (Ait.) Benth. Subspecies aurea (Fabaceae) in Mice”. Evidence-Based Complementary and Alternative Medicine (2018): 9.
  38. Belayneh YM., et al. “Evaluation of in vivo antidiabetic, antidyslipidemic, and in vitro antioxidant activities of hydromethanolic root extract of Datura stramonium L. (Solanaceae)”. Journal of Experimental Pharmacology 11 (2019): 29.
  39. Bailey CJ and C Day. “Traditional plant medicines as treatments for diabetes”. Diabetes Care 8 (1989): 553-564.
  40. Ramkumar KM., et al. “Antidiabetic activity of alcoholic stem extract of Gymnema montanum in streptozotocin-induced diabetic rats”. Food and Chemical Toxicology12 (2011): 3390-3394.
  41. Y Tanko., et al. “Hypoglycaemic effects of the methanol icextract of aerialpart of Chrysan the llumindi cuminrats”. Journal of Natural Product and Plant Resources 1 (2011): 1-7.
  42. Sucharitha E and M Estari. “Evaluation of antidiabetic activity of medicinal plant extracts used by tribal communities in rural areas of Warangal district, Andhra Pradesh, India”. Biology and Medicine 5 (2013): 20.
  43. Kifle ZD., et al. “Hypoglycemic, Anti-Hyperglycemic and Anti-Hyperlipidemic Effects of Bersama abyssinica Fresen (Melianthaceae) Leaves’ Solvent Fractions in Normoglycemic and Streptozotocin-Induced Diabetic Mice”. Journal of Experimental Pharmacology 12 (2020): 385.
  44. Dimo T., et al. “Effect of Sclerocarya birrea (Anacardiaceae) stem bark methylene chloride/methanol extract on streptozotocin-diabetic rats”. Journal of Ethnopharmacology3 (2007): 434-438.
  45. Oliveira HC., et al. “Antidiabetic activity of Vatairea macrocarpa extract in rats”. Journal of Ethnopharmacology3 (2008): 515-519.
  46. Spinas GA. “The dual role of nitric oxide in islet β-cells”. Physiology2 (1999): 49-54.
  47. Kifle ZD and EF Enyew. “Evaluation of in vivo antidiabetic, in vitro α-amylase inhibitory, and in vitro antioxidant activity of leaves crude extract and solvent fractions of bersama abyssinica fresen (melianthaceae)”. Journal of Evidence-Based Integrative Medicine 25 (2020): 2515690X20935827.
  48. Amare GG., et al. “Evaluation of Antidiabetic Activity of the Leaf Latex of Aloe pulcherrima Gilbert and Sebsebe (Aloaceae)”. Evidence-Based Complementary and Alternative Medicine (2020).
  49. He K., et al. “Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients”. Therapeutics and Clinical Risk Management 10 (2014): 505.
  50. Celleno L., et al. “A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women”. International Journal of Medical Sciences1 (2007): 45.
  51. Ivorra M., et al. “A review of natural products and plants as potential antidiabetic drugs”. Journal of Ethnopharmacology3 (1989): 243-275.
  52. Sharma B., et al. “Anti-diabetic potential of alkaloid rich fraction from Capparis decidua on diabetic mice”. Journal of Ethnopharmacology2 (2010): 457-462.
  53. Oliver-Bever B. “Medicinal plants in tropical West Africa”.: Cambridge university press (1986).
  54. Kameswara Rao BGR., et al. “Herbal medicine: in the management of diabetes mellitus”. Manphar Vaidhya Patrika4 (1997): 33-35.
  55. Sezik E., et al. “Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques”. Life Sciences11 (2005): 1223-1238.
  56. Alexandru V., et al. “Antioxidant activity, phenolics and flavonoid content of some selected Romanian medicinal plants”. Planta Medica09 (2007): 261.
Citation: Zemene Demelash Kifle., et al. “Pharmacological Evaluation of the Antidiabetic Effect of the Leaf Crude Extract of Hagenia abyssinica on Normoglycemic, Oral Glucose Loaded, and Streptozotocin-Induced Diabetic Mice; A Single Dose Study” EC Pharmacology and Toxicology 10.7 (2022): 26-38.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 03, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.